Genotoxicity evaluation of stearic acid grafted chitosan oligosaccharide nanomicelles

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 751, Issue 2, 2013, Pages 116-126

  Hu, Peng ^a   Wang, Tingting ^a   Xu, Qin ^a   Chang, Yan ^b   Tu, Honggang ^b   Zheng, Yifan ^a   Zhang, Jun ^a   Xu, Yuying ^a   Yang, Jun ^c   Yuan, Hong ^a   Hu, Fuqiang ^a   Zhu, Xinqiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b National Shanghai Center for New Drug Safety Evaluation and Research   (China)

^c HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Chitosan oligosaccharide nanomicelles; Genotoxicity; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; CASPASE 3; CASPASE 9; CHITOSAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OLIGOSACCHARIDE; REACTIVE OXYGEN METABOLITE; SCAVENGER; STEARIC ACID;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; GENOTOXICITY; HUMAN; HUMAN CELL; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REVERTANT;

ANIMALS; CELL LINE, TUMOR; CHITOSAN; COMET ASSAY; DNA DAMAGE; DRUG CARRIERS; MALE; MICE; MICE, INBRED ICR; MICELLES; MICRONUCLEUS TESTS; NANOSTRUCTURES; OLIGOSACCHARIDES; REACTIVE OXYGEN SPECIES; STEARIC ACIDS;

EID: 84874265815     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2012.12.004     Document Type: Article

References (58)

1. Salata O. Applications of nanoparticles in biology and medicine. J. Neurobiol. 2004, 2:3.
2. Zhang J., Xia W., Liu P., Cheng Q., Tahirou T., Gu W., Li B. Chitosan modification and pharmaceutical/biomedical applications. Mar. Drugs 2010, 8:1962-1987.
3. Kato Y., Onishi H., Machida Y. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr. Pharm. Biotechnol. 2003, 4:303-309.
4. Schipper N.G.M., Varum K.M., Stenberg P., Ocklind G., Lennernas H., Artursson P. Chitosans as absorption enhancers of poorly absorbable drugs 3: Influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 1999, 8:335-343.
5. Kojima K., Okamoto Y., Miyatake K., Tamai Y., Shigemasa Y., Minami S. Optimum dose of chitin and chitosan for organization of non-woven fabric in the subcutaneous tissue. Carbohydr. Polym. 2001, 46:235-239.
6. Richardson S.C., Kolbe H.V., Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 1999, 178:231-243.
7. Kumar S.G., Rahman M.A., Lee S.H., Hwang H.S., Kim H.A., Yun J.W. Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 2009, 9:2149-2162.
8. Shon Y.-H. Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides. J. Microbiol. Biotechnol. 2009, 19:629-633.
9. Hu F.Q., Li Y.H., Yuan H., Zeng S. Novel self-aggregates of chitosan oligosaccharide grafted stearic acid: preparation, characterization and protein association. Pharmazie 2006, 61:194-198.
10. Hu F.Q., Zhao M.D., Yuan H., You J., Du Y.Z., Zeng S. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. Int. J. Pharm. 2006, 315:158-166.
11. Du Y.Z., Lu P., Zhou J.P., Yuan H., Hu F.Q. Stearic acid grafted chitosan oligosaccharide micelle as a promising vector for gene delivery system: factors affecting the complexation. Int. J. Pharm. 2010, 391:260-266.
12. You J., Hu F.Q., Du Y.Z., Yuan H., Ye B.F. High cytotoxicity and resistant-cell reversal of novel paclitaxel loaded micelles by enhancing the molecular-target delivery of the drug. Nanotechnology 2007, 18:495101.
13. Yun Y.H., Jiang H., Chan R., Chen W. Sustained release of PEG-g-chitosan complexed DNA from poly(lactide-co-glycolide). J. Biomater. Sci., Polym. Ed. 2005, 16:1359-1378.
14. Xu Y.Y., Du Y.Z., Yuan H., Liu L.N., Niu Y.P., Hu F.Q. Improved cytotoxicity and multidrug resistance reversal of chitosan based polymeric micelles encapsulating oxaliplatin. J. Drug Targeting 2011, 19:344-353.
15. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Kreyling W., Cox C. Translocation of inhaled ultrafine particles to the brain. Inhalation Toxicol. 2004, 16:437-445.
16. Sarnat J.A., Schwartz J., Suh H.H. Fine particulate air pollution and mortality in 20 US cities. N. Engl. J. Med. 2001, 344:1253-1254.
17. Pope C.A., Burnett R.T., Thun M.J., Calle E.E., Krewski D., Ito K., Thurston G.D. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002, 287:1132-1141.
18. Ahamed M., Akhtar M.J., Siddiqui M.A., Ahmad J., Musarrat J., Al-Khedhairy A.A., AlSalhi M.S., Alrokayan S.A. Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells. Toxicology 2011, 283:101-108.
19. Guo Y.Y., Zhang J., Zheng Y.F., Yang J., Zhu X.Q. Cytotoxic and genotoxic effects of multi-wall carbon nanotubes on human umbilical vein endothelial cells in vitro. Mutat. Res. 2011, 721:184-191.
20. Maenosono S., Suzuki T., Saita S. Mutagenicity of water-soluble FePt nanoparticles in Ames test. J. Toxicol. Sci. 2007, 32:575-579.
21. Yang X., Liu J., He H., Zhou L., Gong C., Wang X., Yang L., Yuan J., Huang H., He L., Zhang B., Zhuang Z. SiO2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells. Part Fibre Toxicol. 2010, 7:1.
22. Trouiller B., Reliene R., Westbrook A., Solaimani P., Schiestl R.H. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 2009, 69:8784-8789.
23. Park M., Lynch I., Ramirez-Garcia S., Dawson K.A., de la Fonteyne L., Gremmer E., Slob W., Briede J.J., Elsaesser A., Howard C.V., van Loveren H., de Jong W.H. In vitro evaluation of cytotoxic and inflammatory properties of silica nanoparticles of different sizes in murine RAW 264.7 macrophages. J. Nanopart. Res. 2011, 13:6775-6787.
24. Ahmad I., Khan M.I., Patil G., Chauhan L.K. Evaluation of cytotoxic, genotoxic and inflammatory responses of micro- and nano-particles of granite on human lung fibroblast cell IMR-90. Toxicol. Lett. 2012, 208:300-307.
25. Foldbjerg R., Dang D.A., Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch. Toxicol. 2011, 85:743-750.
26. Liu H.L., Zhang Y.L., Yang N., Zhang Y.X., Liu X.Q., Li C.G., Zhao Y., Wang Y.G., Zhang G.G., Yang P., Guo F., Sun Y., Jiang C.Y. A functionalized single-walled carbon nanotube-induced autophagic cell death in human lung cells through Akt-TSC2-mTOR signaling. Cell Death Dis 2011, 2:e159.
27. Li C.G., Liu H.L., Sun Y., Wang H.L., Guo F., Rao S.A., Deng J.J., Zhang Y.L., Miao Y.F., Guo C.Y., Meng J., Chen X.P., Li L.M., Li D.S., Xu H.Y., Wang H., Li B., Jiang C.Y. PAMAM nanoparticles promote acute lung injury by inducing autophagic cell death through the Akt-TSC2-mTOR Signaling Pathway. J Mol Cell Biol 2009, 1:37-45.
28. Bernkop-Schnurch A., Krajicek M.E. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J. Controlled Release 1998, 50:215-223.
29. Ames B.N., McCann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 1975, 31:347-364.
30. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.
31. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
32. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Biol. Med. 1999, 27:612-616.
33. Myhre O., Andersen J.M., Aarnes H., Fonnum F. Evaluation of the probes 2',7'-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem. Pharmacol. 2003, 65:1575-1582.
34. van Engeland M., Ramaekers F.C., Schutte B., Reutelingsperger C.P. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 1996, 24:131-139.
35. Berasain C., Garcia-Trevijano E.R., Castillo J., Erroba E., Santamaria M., Lee D.C., Prieto J., Avila M.A. Novel role for amphiregulin in protection from liver injury. J. Biol. Chem. 2005, 280:19012-19020.
36. Ahamed M., Posgai R., Gorey T.J., Nielsen M., Hussain S.M., Rowe J.J. Silver nanoparticles induced heat shock protein 70, oxidative stress and apoptosis in Drosophila melanogaster. Toxicol. Appl. Pharmacol. 2010, 242:263-269.
37. Cunningham D., Littleford R.E., Smith W.E., Lundahl P.J., Khan I., McComb D.W., Graham D., Laforest N. Practical control of SERRS enhancement. Faraday Discuss. 2006, 132:135-145. discussion 147-158.
38. Lukyanov A.N., Torchilin V.P. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv. Drug Delivery Rev. 2004, 56:1273-1289.
39. Mortelmans K., Zeiger E. The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 2000, 455:29-60.
40. Dube A., Nicolazzo J.A., Larson I. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability. Eur. J. Pharm. Sci. 2011, 44:422-426.
41. Yoon S.P., Han M.S., Kim J.W., Chang I.Y., Kim H.L., Chung J.H., Shin B.C. Protective effects of chitosan oligosaccharide on paraquat-induced nephrotoxicity in rats. Food Chem. Toxicol. 2011, 49:1828-1833.
42. Nakagawa Y., Wakuri S., Sakamoto K., Tanaka N. The photogenotoxicity of titanium dioxide particles. Mutat. Res. 1997, 394:125-132.
43. Warheit D.B., Hoke R.A., Finlay C., Donner E.M., Reed K.L., Sayes C.M. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol. Lett. 2007, 171:99-110.
44. Kisin E.R., Murray A.R., Keane M.J., Shi X.C., Schwegler-Berry D., Gorelik O., Arepalli S., Castranova V., Wallace W.E., Kagan V.E., Shvedova A.A. Single-walled carbon nanotubes: geno- and cytotoxic effects in lung fibroblast V79 cells. J. Toxicol. Environ. Health A 2007, 70:2071-2079.
45. Dufour E.K., Kumaravel T., Nohynek G.J., Kirkland D., Toutain H. Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: Genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Mutat. Res. 2006, 607:215-224.
46. Landsiedel R., Kapp M.D., Schulz M., Wiench K., Oesch F. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations--many questions, some answers. Mutat. Res. 2009, 681:241-258.
47. Kim Y.-J., Yu M., Park H.-O., Yang S.I. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by silica nanomaterials in human neuronal cell line. Mol. Cell Toxicol 2010, 6:336-343.
48. Ahamed M. Toxic response of nickel nanoparticles in human lung epithelial A549 cells. Toxicol. in Vitro 2011, 25:930-936.
49. Barillet S., Jugan M.L., Laye M., Leconte Y., Herlin-Boime N., Reynaud C., Carriere M. In vitro evaluation of SiC nanoparticles impact on A549 pulmonary cells: cyto-, genotoxicity and oxidative stress. Toxicol. Lett. 2010, 198:324-330.
50. Sohaebuddin S.K., Thevenot P.T., Baker D., Eaton J.W., Tang L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol 2010, 7:22.
51. Li J.J., Zou L., Hartono D., Ong C.N., Bay B.H., Yung L.Y.L. Gold nanoparticles induce oxidative damage in lung fibroblasts in vitro. Adv. Mater. 2008, 20:138-142.
52. Li J.J., Hartono D., Ong C.N., Bay B.H., Yung L.Y. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 2010, 31:5996-6003.
53. Singh N., Manshian B., Jenkins G.J., Griffiths S.M., Williams P.M., Maffeis T.G., Wright C.J., Doak S.H. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009, 30:3891-3914.
54. Lu X., Qian J., Zhou H., Gan Q., Tang W., Lu J., Yuan Y., Liu C. In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells. Int. J. Nanomed. 2011, 6:1889-1901.
55. Nakajima H., Magae J., Tsuruga M., Sakaguchi K., Fujiwara I., Mizuta M., Sawai K., Yamagishi H., Mizuta N. Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate. Cancer Lett. 2007, 253:89-96.
56. Takadera T., Ohyashiki T. Caspase-dependent apoptosis induced by calcineurin inhibitors was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical cells. Brain Res. 2007, 1133:20-26.
57. Tang X., Guo Y., Nakamura K., Huang H., Hamblin M., Chang L., Villacorta L., Yin K., Ouyang H., Zhang J. Nitroalkenes induce rat aortic smooth muscle cell apoptosis via activation of caspase-dependent pathways. Biochem. Biophys. Res. Commun. 2010, 397:239-244.
58. Hitomi J., Christofferson D.E., Ng A., Yao J., Degterev A., Xavier R.J., Yuan J. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135:1311-1323.